Usual Care Intervention Research Evaluating the Impact of a Personalized Pharmaceutical Plan on the Duration of Opioid Treatment in Non-cancerous Pain
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Total duration of opioid treatment
研究概览
简要总结
Many treatments with WHO grade III opioids are being introduced in the rheumatology department for non-cancerous pain. The duration of this treatment prescribed at discharge is often uncontrolled and sometimes leads to significant addiction.
The team at the local pain center recommends an average duration of 28 days for this type of pain. There is a full-time pharmacy intern in the rheumatology department.
The aim of this work is to evaluate the impact of a targeted pharmaceutical interview on the duration of the morphine treatment initiated during hospitalization.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age ≥ 18 and < 75 years old when entering the rheumatology department
- •Hospitalization in the rheumatology department
- •Patient with acute non-traumatic musculoskeletal disease
- •Patient not taking grade III opioid treatment
- •Patient affiliated to a social security scheme
- •Patient having read and understood the information letter and signed the consent form
- •Patient present on a day which the pharmacy intern is present
排除标准
- •Presence of cancer, fibromyalgia, already diagnosed at inclusion
- •Patient does not understand French
- •Patient with Current or past opioid addiction
- •Person deprived of liberty by administrative or judicial decision
研究组 & 干预措施
Patient with targeted pharmaceutical interview
Specific information about treatment delivered by pharmacist
干预措施: Discharge conciliation interview (Behavioral)
Patient with targeted pharmaceutical interview
Specific information about treatment delivered by pharmacist
干预措施: Admission conciliation interview (Behavioral)
Patient without targeted pharmaceutical interview
No Specific information about treatment delivered by pharmacist
干预措施: Admission conciliation interview (Behavioral)
Patient with targeted pharmaceutical interview
Specific information about treatment delivered by pharmacist
干预措施: Targeted pharmaceutical interview (Behavioral)
Patient without targeted pharmaceutical interview
No Specific information about treatment delivered by pharmacist
干预措施: Discharge conciliation interview (Behavioral)
结局指标
主要结局
Total duration of opioid treatment
时间窗: 6 months
次要结局
- Rate of patients exceeding 28 days of cumulative duration of treatment(6 months)
- Rate of patients exceeding 90 days of cumulative duration of treatment(6 months)